Potent activity of 2'-β-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice
- Author
- RUXRUNGTHAM, K1 ; BOONE, E1 ; FORD, H. JR2 ; DRISCOLL, J. S2 ; DAVEY, R. T1 ; LANE, H. C1
[1] Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, United States
[2] Laboratory of Medicinal Chemistry, National Cancer Institute, Bethesda, Maryland 20892, United States - Source
Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 10, pp 2369-2374 ; ref : 23 ref
- CODEN
- AACHAX
- ISSN
- 0066-4804
- Scientific domain
- Microbiology, infectious diseases; Pharmacology drugs
- Publisher
- American Society for Microbiology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Analogue Animal Antiviral Chimiothérapie Immunodéficit Inhibiteur enzyme Lymphocyte T Nucléoside RNA-directed DNA polymerase Souris Traitement Virus HIV1 Voie orale FddA Enzyme Immunopathologie Lentivirinae Mammalia Nucleotidyltransferases Retroviridae Rodentia Transferases Vertebrata Virus immunodéficience humaine Virus
- Keyword (en)
- Analog Animal Antiviral Chemotherapy Immune deficiency Enzyme inhibitor T-Lymphocyte Nucleoside RNA-directed DNA polymerase Mouse Treatment HIV-1 virus Oral administration Enzyme Immunopathology Lentivirinae Mammalia Nucleotidyltransferases Retroviridae Rodentia Transferases Vertebrata Human immunodeficiency virus Virus
- Keyword (es)
- Análogo Animal Antiviral Quimioterapia Inmunodeficiencia Inhibidor enzima Linfocito T Nucleósido RNA-directed DNA polymerase Ratón Tratamiento HIV-1 virus Vía oral Enzima Inmunopatología Lentivirinae Mammalia Nucleotidyltransferases Retroviridae Rodentia Transferases Vertebrata Human immunodeficiency virus Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3238681
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1128/AAC.40.10.2369 
https://dx.doi.org/10.1128/AAC.40.10.2369
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1128\/AAC.40.10.2369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2369\";s:8:\"\u0000*\u0000epage\";s:4:\"2374\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"RUXRUNGTHAM\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"BOONE, E\";i:1;s:11:\"FORD, H. JR\";i:2;s:14:\"DRISCOLL, J. S\";i:3;s:11:\"DAVEY, R. T\";i:4;s:10:\"LANE, H. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1128\/AAC.40.10.2369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2369\";s:8:\"\u0000*\u0000epage\";s:4:\"2374\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"RUXRUNGTHAM\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"BOONE, E\";i:1;s:11:\"FORD, H. JR\";i:2;s:14:\"DRISCOLL, J. S\";i:3;s:11:\"DAVEY, R. T\";i:4;s:10:\"LANE, H. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1128\/AAC.40.10.2369\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1128\/AAC.40.10.2369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2369\";s:8:\"\u0000*\u0000epage\";s:4:\"2374\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"RUXRUNGTHAM\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"BOONE, E\";i:1;s:11:\"FORD, H. JR\";i:2;s:14:\"DRISCOLL, J. S\";i:3;s:11:\"DAVEY, R. T\";i:4;s:10:\"LANE, H. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1128\/AAC.40.10.2369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2369\";s:8:\"\u0000*\u0000epage\";s:4:\"2374\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"RUXRUNGTHAM\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"BOONE, E\";i:1;s:11:\"FORD, H. JR\";i:2;s:14:\"DRISCOLL, J. S\";i:3;s:11:\"DAVEY, R. T\";i:4;s:10:\"LANE, H. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1128\/AAC.40.10.2369\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Antimicrobial agents and chemotherapy\";s:9:\"\u0000*\u0000stitle\";s:28:\"Antimicrob. agents chemother\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2369\";s:8:\"\u0000*\u0000epage\";s:4:\"2374\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0066-4804\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:11:\"RUXRUNGTHAM\";s:10:\"\u0000*\u0000aufirst\";s:1:\"K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:8:\"BOONE, E\";i:1;s:11:\"FORD, H. JR\";i:2;s:14:\"DRISCOLL, J. S\";i:3;s:11:\"DAVEY, R. T\";i:4;s:10:\"LANE, H. C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AACHAX\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:128:\"Potent activity of 2'-\u03b2-fluoro-2'-3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
